Reversal of liver damage due to long term methyltestosterone and safety of non-17 alpha-alkylated androgens.
作者信息
Lowdell C P, Murray-Lyon I M
出版信息
Br Med J (Clin Res Ed). 1985 Sep 7;291(6496):637. doi: 10.1136/bmj.291.6496.637.
Abstract
摘要
相似文献
1
Reversal of liver damage due to long term methyltestosterone and safety of non-17 alpha-alkylated androgens.长期使用甲基睾酮所致肝损伤的逆转及非17α-烷基化雄激素的安全性
Br Med J (Clin Res Ed). 1985 Sep 7;291(6496):637. doi: 10.1136/bmj.291.6496.637.
2
Liver damage from long-term methyltestosterone.长期使用甲基睾酮导致的肝损伤。
Lancet. 1977 Aug 20;2(8034):400-1. doi: 10.1016/s0140-6736(77)90323-3.
3
Female pseudo-hermaphrodite presenting with bilateral cryptorchidism.表现为双侧隐睾的女性假两性畸形。
Br Med J. 1966 Jan 29;1(5482):279-80. doi: 10.1136/bmj.1.5482.279.
4
Anabolic agents: clinical efficacy versus side effects.合成代谢药物：临床疗效与副作用
J Am Med Womens Assoc. 1968 Apr;23(4):352-69.
5
Liver damage from long-term methyltestosterone.
Lancet. 1977 Aug 6;2(8032):262-3.
6
Androgenic and anabolic hormones.雄激素和合成代谢激素。
Med Lett Drugs Ther. 1966 May 6;8(9):35-6.
7
Acute hepatitis induced by replacement oral testosterone product in a female-to-male patient with gender identity disorder.一名患有性别认同障碍的女性向男性转变的患者因更换口服睾酮产品引发急性肝炎。
Int J Urol. 2009 May;16(5):530-1. doi: 10.1111/j.1442-2042.2008.02222.x.
8
Hepatic complications of androgen therapy.
Gastroenterology. 1977 Dec;73(6):1461.
9
Peliosis hepatis in a child.儿童肝紫癜病
Acta Paediatr Scand. 1978 Jan;67(1):105-7. doi: 10.1111/j.1651-2227.1978.tb16285.x.
10
[Is methyltestosterone no longer used therapeutically?].[甲基睾酮不再用于治疗了吗？]
Dtsch Med Wochenschr. 1981 Sep 4;106(36):1123-5. doi: 10.1055/s-2008-1070466.
引用本文的文献
1
A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism.一种新的口服睾酮（TLANDO）治疗方案，无需剂量滴定，适用于男性性腺功能减退症。
Andrology. 2022 May;10(4):669-676. doi: 10.1111/andr.13153. Epub 2022 Jan 18.
2
Pharmacokinetics of modified slow-release oral testosterone over 9 days in normal men with experimental hypogonadism.实验性性腺功能减退的正常男性中改良缓释口服睾酮9天的药代动力学
J Androl. 2012 May-Jun;33(3):420-6. doi: 10.2164/jandrol.111.014514. Epub 2011 Aug 25.
3
Pharmacokinetics of 2 novel formulations of modified-release oral testosterone alone and with finasteride in normal men with experimental hypogonadism.两种新型缓释口服睾酮制剂单独及与非那雄胺联合应用于实验性性腺功能减退正常男性的药代动力学研究。
J Androl. 2010 Nov-Dec;31(6):527-35. doi: 10.2164/jandrol.109.009746. Epub 2010 Apr 8.
4
Pharmacokinetics of a new testosterone transdermal delivery system, TDS-testosterone in healthy males.一种新型睾酮透皮给药系统（TDS-睾酮）在健康男性中的药代动力学
Br J Clin Pharmacol. 2006 Mar;61(3):275-9. doi: 10.1111/j.1365-2125.2005.02542.x.
5
Recent developments in the toxicology of anabolic steroids.合成代谢类固醇毒理学的最新进展。
Drug Saf. 1990 Nov-Dec;5(6):458-76. doi: 10.2165/00002018-199005060-00007.
本文引用的文献
1
Hepatic lesions in patients on anabolic androgenic therapy.接受合成代谢雄激素治疗患者的肝脏病变
Isr J Med Sci. 1983 Apr;19(4):332-7.
2
Hepatic lesions caused by anabolic and contraceptive steroids.合成代谢类固醇和避孕类固醇引起的肝脏病变。
Semin Liver Dis. 1981 May;1(2):116-28. doi: 10.1055/s-2008-1040724.
3
[Anabolic steroids and cholestasis].[合成代谢类固醇与胆汁淤积]
Med Chir Dig. 1974;3(3):167-71.
4
Hyperplasia and prolapse of hepatocytes into hepatic veins during longterm methyltestosterone therapy: possible relationships of these changes to the developement of peliosis hepatis and liver tumours.长期甲基睾酮治疗期间肝细胞增生及突入肝静脉：这些改变与肝紫癜和肝肿瘤发生的可能关系。
Histopathology. 1977 Jul;1(4):225-46. doi: 10.1111/j.1365-2559.1977.tb01663.x.
Zotero 插件